What changed
$LRCX — AVOID 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | Rev $5.8B | EPS $1.47 vs $1.36 🟢 | Margin 35.0%
💡 Consensus appears to be pricing in sustained high growth and a re-rating permanence. Our variant view is that the 60.3x multiple embeds unrealistic earnings acceleration (e.g., TTM EPS of ~$6.6 rising to $10+ within a year). Even with the EPS beat, forward earnings growth may disappoint, leading to multiple contraction.
📉 Reward/risk: 1.3:1
🏢 Business Quality: 8/10 - Leading etch and deposition franchise with sticky customer base and high R&D moat, but cyclicality and capex dependency limit resilience.
📊 Valuation: rich — TTM P/E 60.3x vs. long-term historical median ~15x; EV/EBITDA (est. 40x+); FCF yield sub-2%. All methods indicate extreme premium.
🔮 Catalyst: Forward guidance uplift or major AI fab spend announcement
📊 Our read: AVOID. Full analysis →
https://stockduty.xyz/s/LRCX0617